ELEV logo

Elevation Oncology (ELEV) Company Overview

Profile

Full Name:

Elevation Oncology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 25, 2021

Indexes:

Not included

Description:

Elevation Oncology focuses on developing targeted therapies for patients with genomically defined cancers. The company aims to improve treatment options by leveraging precision medicine, specifically targeting genetic mutations that drive cancer growth, ultimately enhancing patient outcomes and quality of life.

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 14, 25 HC Wainwright & Co.
Buy
Jan 3, 25 William Blair
Outperform
Dec 19, 24 JMP Securities
Market Outperform
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 6, 24 Stephens & Co.
Overweight
Aug 7, 24 HC Wainwright & Co.
Buy
Jul 15, 24 JMP Securities
Market Outperform
Jun 28, 24 JMP Securities
Market Outperform
May 31, 24 Piper Sandler
Overweight
May 14, 24 Stephens & Co.
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Elevation Oncology?
  • Does Elevation Oncology pay dividends?
  • What sector is Elevation Oncology in?
  • What industry is Elevation Oncology in?
  • What country is Elevation Oncology based in?
  • When did Elevation Oncology go public?
  • Is Elevation Oncology in the S&P 500?
  • Is Elevation Oncology in the NASDAQ 100?
  • Is Elevation Oncology in the Dow Jones?
  • When was Elevation Oncology's last earnings report?
  • When does Elevation Oncology report earnings?
  • Should I buy Elevation Oncology stock now?

What is the ticker symbol for Elevation Oncology?

The ticker symbol for Elevation Oncology is NASDAQ:ELEV

Does Elevation Oncology pay dividends?

No, Elevation Oncology does not pay dividends

What sector is Elevation Oncology in?

Elevation Oncology is in the Healthcare sector

What industry is Elevation Oncology in?

Elevation Oncology is in the Biotechnology industry

What country is Elevation Oncology based in?

Elevation Oncology is headquartered in United States

When did Elevation Oncology go public?

Elevation Oncology's initial public offering (IPO) was on June 25, 2021

Is Elevation Oncology in the S&P 500?

No, Elevation Oncology is not included in the S&P 500 index

Is Elevation Oncology in the NASDAQ 100?

No, Elevation Oncology is not included in the NASDAQ 100 index

Is Elevation Oncology in the Dow Jones?

No, Elevation Oncology is not included in the Dow Jones index

When was Elevation Oncology's last earnings report?

Elevation Oncology's most recent earnings report was on Nov 6, 2024

When does Elevation Oncology report earnings?

The next expected earnings date for Elevation Oncology is Mar 6, 2025

Should I buy Elevation Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions